ScoreWhy is Biogened SA ?
1
The company is Net-Debt Free
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 8.84% signifying low profitability per unit of shareholders funds
2
With a growth in Net Profit of 10.58%, the company declared Very Positive results in Mar 26
- OPERATING CASH FLOW(Y) Highest at PLN 9.38 MM
- RAW MATERIAL COST(Y) Fallen by -6.07% (YoY)
- CASH AND EQV(HY) Highest at PLN 13.46 MM
3
With ROE of 10.30%, it has a attractive valuation with a 0.96 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -30.83%, its profits have risen by 1.9% ; the PEG ratio of the company is 4.9
4
Below par performance in long term as well as near term
- Along with generating -30.83% returns in the last 1 year, the stock has also underperformed Poland WIG in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Biogened SA should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Biogened SA for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Biogened SA
-23.97%
-0.11
63.18%
Poland WIG
29.57%
1.74
17.24%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
17.18%
EBIT Growth (5y)
24.18%
EBIT to Interest (avg)
4.85
Debt to EBITDA (avg)
1.29
Net Debt to Equity (avg)
0.40
Sales to Capital Employed (avg)
1.71
Tax Ratio
33.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
16.92%
ROE (avg)
8.84%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
9
Industry P/E
Price to Book Value
0.96
EV to EBIT
6.73
EV to EBITDA
4.53
EV to Capital Employed
0.97
EV to Sales
0.58
PEG Ratio
4.93
Dividend Yield
135.87%
ROCE (Latest)
14.40%
ROE (Latest)
10.30%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bearish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend9What is working for the Company
OPERATING CASH FLOW(Y)
Highest at PLN 9.38 MM
RAW MATERIAL COST(Y)
Fallen by -6.07% (YoY
CASH AND EQV(HY)
Highest at PLN 13.46 MM
OPERATING PROFIT(Q)
Highest at PLN 5.97 MM
OPERATING PROFIT MARGIN(Q)
Highest at 21.08 %
PRE-TAX PROFIT(Q)
Highest at PLN 3.82 MM
NET PROFIT(Q)
Highest at PLN 2.56 MM
EPS(Q)
Highest at PLN 1.04
-1What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Biogened SA
Operating Cash Flow
Highest at PLN 9.38 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (PLN MM)
Operating Profit
Highest at PLN 5.97 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (PLN MM)
Operating Profit Margin
Highest at 21.08 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at PLN 3.82 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (PLN MM)
Net Profit
Highest at PLN 2.56 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (PLN MM)
EPS
Highest at PLN 1.04
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (PLN)
Cash and Eqv
Highest at PLN 13.46 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -6.07% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at PLN 1.31 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (PLN MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
